Showing results (1-10 of 632) with videos related to
Sort By:
Pageof 64
British Journal of Cancer|October 1, 1987
3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancerR E Coleman, R D RubensBritish Journal of Cancer|January 1, 1987
The clinical course of bone metastases from breast cancerR E Coleman, R D RubensJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1988
Reappraisal of the baseline bone scan in breast cancerR E Coleman, R D Rubens, I FogelmanEuropean Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 1, 1988
Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastasesR E Coleman, I Fogelman, R D RubensBritish Journal of Cancer|February 14, 1998
Clinical course and prognostic factors following bone recurrence from breast cancerR E Coleman, P Smith, R D RubensCancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of mitoxantrone for liver metastases from breast cancerS M O'Reilly, R E Coleman, R D RubensNuclear Medicine Communications|July 1, 1988
Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancerR E Coleman, C A Meier, R D Rubens, et al.European Journal of Cancer & Clinical Oncology|June 1, 1984
Mitoxantrone in advanced breast cancer--a phase II study with special attention to cardiotoxicityR E Coleman, M N Maisey, R K Knight, et al.British Journal of Cancer|November 1, 1988
Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)R E Coleman, P J Woll, M Miles, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1990
Selection of patients with breast cancer for routine follow-up bone scansR E Coleman, I Fogelman, F Habibollahi, et al.Pageof 64